Chimeric antigen receptor T-cell therapy: a promising treatment modality for relapsed/refractory mantle cell lymphoma

{{article.zuoZheEn}}

PDF(990 KB)
PDF(990 KB)
Front. Med. ›› 2020, Vol. 14 ›› Issue (6) : 811-815. DOI: 10.1007/s11684-020-0740-6
COMMENTARY

Chimeric antigen receptor T-cell therapy: a promising treatment modality for relapsed/refractory mantle cell lymphoma

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Front. Med., 2020, 14(6): 811‒815 https://doi.org/10.1007/s11684-020-0740-6

References

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
Share on Mendeley
PDF(990 KB)

Accesses

Citations

Detail

Sections
Recommended

/